| 注册
首页|期刊导航|中国医学工程|PCNA与BCL-2的表达在大肠癌预后评估中的意义

PCNA与BCL-2的表达在大肠癌预后评估中的意义

李异凡 何剪太 卢焕元 李年丰

中国医学工程2003,Vol.11Issue(6):33-37,44,6.
中国医学工程2003,Vol.11Issue(6):33-37,44,6.

PCNA与BCL-2的表达在大肠癌预后评估中的意义

Prognostic evaluation of PCNA and BCL-2 expression in colorectal carcinoma

李异凡 1何剪太 1卢焕元 1李年丰1

作者信息

  • 1. 中南大学生物医学工程研究院,湖南,长沙,410008
  • 折叠

摘要

Abstract

Objective:To investigate the prognostic evaluation of PCNA and BCL - 2 expression in patients with colorectal carcinoma. Methods: Utilizing sABC Immunohistochemical methods, PCNA and BCL- 2 expression of specimens from patients with colorectal carcinoma during a three- year follow- up were analyzed. Results: PCNA and BCL - 2 expression was negative in normal colorectal mucossae but positive in colorectal carcinoma. PCNA demonstrated a positive correlation (P< 0.05) with the recurrence and death time of patient, tumor stage and lymphatic metastasis, but a negative correlation with patient's age, gender and tumor location. BCL-2 only shared a highly positive correlation ( P < 0.05) with tumor stage and no obvious correlation (P > 0.05) with such factors as recurrence time, death time, age, gender and tumor location. Conclusions:PCNA and BCL - 2 expression analysis is of important value in clinical treatment and prognostic evaluation of colorectal carcinoma.

关键词

大肠癌/基因表达/BCL-2/增殖细胞核抗原(PCNA)/预后评估

Key words

colorectal carcinoma/gene expression/B - cell lymphoma - 2 ( BCL - 2)/Proliferating Cell Nuclear Antigen (PCNA)/prognostic evaluation

分类

医药卫生

引用本文复制引用

李异凡,何剪太,卢焕元,李年丰..PCNA与BCL-2的表达在大肠癌预后评估中的意义 [J].中国医学工程,2003,11(6):33-37,44,6.

基金项目

Supported by Key Technologies R&D programme of the tenth five- year plan in China (No. 2001BA706B- 15) (No. 2001BA706B- 15)

中国医学工程

1672-2019

访问量0
|
下载量0
段落导航相关论文